NCT02689284 · Interventional trial
Combination Margetuximab and Pembrolizumab for Advanced, Metastatic HER2(+) Gastric or Gastroesophageal Junction Cancer
Overall registry status Completed
Phase 1 · Phase 2
Conditions Esophageal Cancer, Gastric Cancer, Stomach Cancer
Delaware Valley sites
- Fox Chase Cancer Center · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory